Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-14-000101
Filing Date
2014-05-15
Accepted
2014-05-14 17:40:34
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 sangui10qmar2014vedgar4.htm 10-Q 374888
2 exhibit3101vedgar1.htm EX-31 7999
3 exhibit3102vedgar1.htm EX-31 8560
4 exhibit3201vedgar1.htm EX-32 4817
  Complete submission text file 0001551163-14-000101.txt   1038318

Data Files

Seq Description Document Type Size
5 sgbi-20140331.xml EX-101.INS 47368
6 sgbi-20140331.xsd EX-101.SCH 6671
7 sgbi-20140331_cal.xml EX-101.CAL 11781
8 sgbi-20140331_def.xml EX-101.DEF 4614
9 sgbi-20140331_lab.xml EX-101.LAB 68947
10 sgbi-20140331_pre.xml EX-101.PRE 52582
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 14842825
SIC: 2834 Pharmaceutical Preparations